Granulocyte colony-stimulating factor has differing effects comparing intravascular versus extravascular models of sepsis.
Sevransky
Jonathan E
JE
Division of Pulmonary and Critical Care Medicine, Johns Hopkins Asthma and Allergy Center, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Parent
Chantal
C
Cui
Xizhong
X
Karzai
Waheed
W
Fitz
Yvonne
Y
Banks
Steven M
SM
Gerstenberger
Eric
E
Danner
Robert L
RL
Natanson
Charles
C
Eichacker
Peter Q
PQ
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004927:Escherichia coli Infections / Q000209:etiology / Q000517:prevention & control*; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D008297:Male; D009504:Neutrophils / Q000187:drug effects*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018805:Sepsis / Q000209:etiology / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000209:etiology / Q000517:prevention & control*; D013318:Stroke Volume / Q000187:drug effects; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D000900:Anti-Bacterial Agents; D014409:Tumor Necrosis Factor-alpha; D016179:Granulocyte Colony-Stimulating Factor